FY25 B5 trinity biotech hemo analyzer annual BPC against FSS BPA for (2) two hemoglobin A1C analyzers, including all clinical material and required service for the U.S. Medical center for federal…
Ended Awarded Last action
- Contract number
- 15B41424F00000206
- Awardee
-
Biopool U.s., Inc. UEI JBELQXBFTJ18
- Awarding agency
-
Medical Center for Federal Prisoners Springfield
Correctional Facilities, Department of Justice
- Obligated
- $48,130
Award facts
- Contract value 100% obligated
- $48,129.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Jamestown, NY 14701, USA
- Legislative mandates
-
- Davis-Bacon Act FAR subpart 22.4
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $1,330 | |
| Funding Only Action | $6,900 | |
| Funding Only Action | $11,250 | |
| Funding Only Action | $6,650 | |
| Funding Only Action | $2,050 | |
| Supplemental Agreement for work within scope | $9,950 | |
| Funding Only Action | $10,000 | |
| Original award | $0 |
About this award
Biopool U.S., Inc., operating as Trinity Biotech Distribution, received a Firm Fixed Price BPA call modification totaling $48,129.74 against the General Services Administration's Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) to support the U.S. Medical Center for Federal Prisoners in Springfield, Missouri. The modification increases estimated funding for the FY25 period to cover invoices received during the applicable timeframe for two hemoglobin A1c analyzers and associated clinical materials and service support. The contract carries no set-aside designation and is scheduled for completion by September 30, 2025, with performance occurring at the contractor's facility in Jamestown, New York.
This award represents a continuation of the contractor's ongoing relationship with the federal prison healthcare system, built on a parent BPA valued at $199,500 established October 1, 2023. Biopool U.S., Inc. is a foreign-owned subsidiary of Ireland-based Trinity Biotech PLC and serves as a key federal supplier of hemoglobin A1c testing equipment and clinical laboratory diagnostics across multiple agencies, including the Veterans Affairs system and Defense Logistics Agency. The company currently maintains approximately $58.87 million in active federal contract ceiling value across five indefinite delivery vehicles, demonstrating sustained federal reliance on the contractor's specialized laboratory diagnostic capabilities.
Description
FY25 B5 trinity biotech hemo analyzer annual BPC against FSS BPA for (2) two hemoglobin A1C analyzers, including all clinical material and required service for the U.S. Medical center for federal prisoners, springfield, MO
Quick answers
Who was awarded contract 15B41424F00000206?
15B41424F00000206 was awarded to Biopool U.s., Inc. by Medical Center for Federal Prisoners Springfield (Correctional Facilities) on October 1, 2024.
How much is contract 15B41424F00000206 worth?
The government has obligated $48,130 on 15B41424F00000206.
Is contract 15B41424F00000206 an order under another contract?
Yes. 15B41424F00000206 is a BPA call under V797D40089-15B41423A00000036, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract 15B41424F00000206 competed?
The extent of competition for 15B41424F00000206 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award